Items | FGF-23 (pg/mL), median (IQR) | P value |
---|---|---|
Gender | Â | 0.946 |
 No | 736.6 (634.3–808.5) |  |
 Yes | 736.5 (608.0–905.8) |  |
Current smoke | Â | 0.700 |
 No | 727.9 (608.2–907.5) |  |
 Yes | 752.0 (661.8–855.1) |  |
Hypertension | Â | 0.167 |
 No | 706.2 (571.8–887.1) |  |
 Yes | 748.1 (641.0–886.0) |  |
Diabetes mellitus | Â | 0.201 |
 No | 720.9 (587.0–862.8) |  |
 Yes | 749.6 (657.8–907.5) |  |
Hypercholesteremia |  | < 0.001 |
 No | 582.7 (482.5–694.4) |  |
 Yes | 798.6 (720.0–988.4) |  |
Hyperuricemia | Â | 0.022 |
 No | 715.8 (575.8–901.7) |  |
 Yes | 766.4 (672.5–870.8) |  |
Family history of CAD | Â | 0.022 |
 No | 729.5 (603.5–848.3) |  |
 Yes | 781.4 (667.5–1005.0) |  |
Multivessel artery lesions | Â | 0.061 |
 No | 691.2 (579.7–795.2) |  |
 Yes | 750.2 (630.4–914.6) |  |
Patients with two target lesions | Â | 0.880 |
 No | 746.5 (630.4–876.7) |  |
 Yes | 721.2 (581.9–892.1) |  |
Target lesion at LAD | Â | 0.628 |
 No | 720.3 (622.4–909.9) |  |
 Yes | 748.9 (603.7–876.9) |  |
Target lesion at LCX | Â | 0.496 |
 No | 741.1 (609.5–896.5) |  |
 Yes | 734.3 (616.5–886.0) |  |
Target lesion at RCA | Â | 0.306 |
 No | 749.6 (636.5–863.3) |  |
 Yes | 698.1 (592.8–912.3) |  |